홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Diisopropylethylamine → 4-[4-{2-[1-(1-methyl-L-prolyl)piperidin-4-yl]ethoxy}-3-(trifluoromethyl)phenyl]-7-(tetrahydrofuran-2-ylmethyl)-7H-pyrrolo[2,3-d]pyrimidine-2-carbonitrile monohydrochloride

HRID 522299
인쇄

반응식

HRID 522299 반응식
[CH3:1][N:2]1[CH2:9][CH2:8][CH2:7][C@H:3]1[C:4]([OH:6])=O.F[P-](F)(F)(F)(F)F.N1(OC(N(C)C)=[N+](C)C)C2N=CC=CC=2N=N1.C(N(CC)C(C)C)(C)C.[ClH:43].[NH:44]1[CH2:49][CH2:48][CH:47]([CH2:50][CH2:51][O:52][C:53]2[CH:58]=[CH:57][C:56]([C:59]3[C:60]4[CH:69]=[CH:68][N:67]([CH2:70][CH:71]5[CH2:75][CH2:74][CH2:73][O:72]5)[C:61]=4[N:62]=[C:63]([C:65]#[N:66])[N:64]=3)=[CH:55][C:54]=2[C:76]([F:79])([F:78])[F:77])[CH2:46][CH2:45]1.C([O-])(O)=O.[Na+]>CN(C=O)C.CCOC(C)=O.O>[ClH:43].[CH3:1][N:2]1[CH2:9][CH2:8][CH2:7][C@H:3]1[C:4]([N:44]1[CH2:45][CH2:46][CH:47]([CH2:50][CH2:51][O:52][C:53]2[CH:58]=[CH:57][C:56]([C:59]3[C:60]4[CH:69]=[CH:68][N:67]([CH2:70][CH:71]5[CH2:75][CH2:74][CH2:73][O:72]5)[C:61]=4[N:62]=[C:63]([C:65]#[N:66])[N:64]=3)=[CH:55][C:54]=2[C:76]([F:77])([F:78])[F:79])[CH2:48][CH2:49]1)=[O:6]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

9

반응물 5

HCID 81531DiisopropylethylamineHCID 516892Sodium BicarbonateHCID 643474N-Methyl-L-prolineHCID 9886157Methanaminium, N-((dimethylamino)(3H-1,2,3-triazolo(4,5-b)pyridin-3-yloxy)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1)HCID 1178996134-{4-[2-(piperidin-4-yl)ethoxy]-3-(trifluoromethyl)phenyl}-7-(tetrahydrofuran-2-yl methyl)-7H-pyrrolo[2,3-d]pyrimidine-2-carbonitrile monohydrochloride

생성물 1

HCID 1180472894-[4-{2-[1-(1-methyl-L-prolyl)piperidin-4-yl]ethoxy}-3-(trifluoromethyl)phenyl]-7-(tetrahydrofuran-2-ylmethyl)-7H-pyrrolo[2,3-d]pyrimidine-2-carbonitrile monohydrochloride수율 79.7%

시약·촉매·용매 3

HCID 962Water용매HCID 6228Dimethylformamide용매HCID 8857Ethyl Acetate용매

실험 절차

1-Methyl-L-proline (33 mg), O-(7-azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate (85 mg), and N,N-diisopropylethylamine (64 μL) were added to a solution of 4-{4-[2-(piperidin-4-yl)ethoxy]-3-(trifluoromethyl)phenyl}-7-(tetrahydrofuran-2-yl methyl)-7H-pyrrolo[2,3-d]pyrimidine-2-carbonitrile monohydrochloride (80 mg) in DMF (1.6 mL) at room temperature, and the mixture was stirred at the same temperature overnight. After the reaction mixture was diluted with EtOAc, a saturated aqueous NaHCO3 solution and water were added thereto, then extraction thereof was performed using EtOAc, and the extract was washed with saturated brine. The organic layer was dried over Na2SO4 and filtered, and the filtrate was concentrated under reduced pressure. The residue was purified by basic silica gel column chromatography (Hex:CHCl3=50:50 to 0:100). The obtained product was dissolved in EtOAc (1 mL), then a 4 M solution of hydrogen chloride in EtOAc (31 μL) was added thereto at room temperature, and the mixture was stirred at the same temperature for 1 hour. The precipitate was collected by filtration, whereby 4-[4-{2-[1-(1-methyl-L-prolyl)piperidin-4-yl]ethoxy}-3-(trifluoromethyl)phenyl]-7-(tetrahydrofuran-2-ylmethyl)-7H-pyrrolo[2,3-d]pyrimidine-2-carbonitrile monohydrochloride (77 mg) was obtained as a pale yellow solid.

후처리

  1. extractionextraction
  2. washthe extract was washed with saturated brine
  3. dry with materialThe organic layer was dried over Na2SO4
  4. filtrationfiltered
  5. concentrationthe filtrate was concentrated under reduced pressure
  6. customThe residue was purified by basic silica gel column chromatography (Hex:CHCl3=50:50 to 0:100)
  7. dissolutionThe obtained product was dissolved in EtOAc (1 mL)
  8. additiona 4 M solution of hydrogen chloride in EtOAc (31 μL) was added
  9. stirringat room temperature, and the mixture was stirred at the same temperature for 1 hour
  10. filtrationThe precipitate was collected by filtration

출처 및 근거

ORD 기록
ord-2144b2668e714530a4574c1cde7d14bb
출처 데이터셋
uspto-grants-2016_05
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US09328118B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트